After GALNS the next biggest value driver IMO is Pompe and since that is open label a suitor could see the data before BMRN reports it (if BMRN allows them). I think they were going to show 20mg data on patients who've completed in an R&D day this fall anyway.
Market Data 
Markets 
AI
